2015
DOI: 10.1017/s0033291715002342
|View full text |Cite
|
Sign up to set email alerts
|

Effect of high-potency cannabis on corpus callosum microstructure

Abstract: BackgroundThe use of cannabis with higher Δ9-tetrahydrocannabinol content has been associated with greater risk, and earlier onset, of psychosis. However, the effect of cannabis potency on brain morphology has never been explored. Here, we investigated whether cannabis potency and pattern of use are associated with changes in corpus callosum (CC) microstructural organization, in patients with first-episode psychosis (FEP) and individuals without psychosis, cannabis users and non-users.MethodThe CC of 56 FEP (3… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
38
0
1

Year Published

2016
2016
2023
2023

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 50 publications
(40 citation statements)
references
References 58 publications
1
38
0
1
Order By: Relevance
“…Moreover, the cross-sectional design, does not allow for a strong cause-effect interpretation of the findings. Furthermore, although other studies that have used self-report measures have also shown an association with brain structural alterations (Rigucci et al 2016), the lack of objective measures of cannabis use in our study is an important limitation. However, there is published evidence indicating that asking patients with psychosis about their use of cannabis is, at least in some situations, more accurate than, or as reliable as, urine or blood testing which can only provide information on recent use (Freeman et al 2014).…”
Section: Strengths and Limitationsmentioning
confidence: 85%
“…Moreover, the cross-sectional design, does not allow for a strong cause-effect interpretation of the findings. Furthermore, although other studies that have used self-report measures have also shown an association with brain structural alterations (Rigucci et al 2016), the lack of objective measures of cannabis use in our study is an important limitation. However, there is published evidence indicating that asking patients with psychosis about their use of cannabis is, at least in some situations, more accurate than, or as reliable as, urine or blood testing which can only provide information on recent use (Freeman et al 2014).…”
Section: Strengths and Limitationsmentioning
confidence: 85%
“…Some neuroimaging studies have also suggested that the MRI correlates of cannabis use may vary with exposure to CBD. One study found that regular use of high-potency cannabis was associated with alterations in the corpus callosum, an effect that was absent in hash users 39 . Two other MRI studies have reported that cannabis users had smaller hippocampal volumes than non-users, but that this was not evident in cannabis users with hair samples that were positive for CBD 40,41 .…”
Section: Psychosismentioning
confidence: 99%
“…Alternative approaches include taxation based on THC content, although further research is needed their impact (including use of more harmful, synthetic cannabinoids). Only very recently have studies differentiated between different types of cannabis based on THC content 30,[37][38][39] , and most of these studies do not involve measures of THC and CBD content, but proxy measures of potency, such as analysis of police seizures or coffee shop cannabis, and a reliance on self-report measures. Although self-report measures are associated with THC and CBD content, these associations are modest and are weaker among infrequent users 84,85 .…”
Section: Making Cannabis Safermentioning
confidence: 99%
“…Another significant factor in the reduction of cognitive processing are the cannabinoid receptors that are primarily located on neurons but also found on myelinating glial cells [49].…”
Section: White Mattermentioning
confidence: 99%